Merck Financials

MRK Stock  MXN 2,064  36.60  1.80%   
We recommend to make use of Merck Company fundamental analysis to see if markets are presently undervaluing or overvaluing the entity. Strictly speaking, this technique allows you to check out available financial ratios of Merck Company as well as the relationship between them. We were able to collect data for thirty-three available fundamentals for Merck, which can be compared to its peers in the industry. The stock experiences a large bullish trend. Check odds of Merck to be traded at 2270.75 in 90 days.
  
Understanding current and past Merck Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Merck's financial statements are interrelated, with each one affecting the others. For example, an increase in Merck's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Merck's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Merck Company. Check Merck's Beneish M Score to see the likelihood of Merck's management manipulating its earnings.

Merck Stock Summary

Merck competes with First Majestic, Genworth Financial, Prudential Financial, Martin Marietta, and Lloyds Banking. It operates through four segments Pharmaceutical, Animal Health, Healthcare Services, and Alliances. Merck Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey. MERCK INC operates under Drug Manufacturers - Major classification in Mexico and is traded on Mexico Stock Exchange. It employs 69000 people.
Foreign Associates
InstrumentMexico Stock View All
ExchangeMexican Exchange
ISINUS58933Y1055
Business Address2000 Galloping Hill
SectorHealthcare
IndustryDrug Manufacturers - Major
BenchmarkDow Jones Industrial
Websitewww.merck.com
Phone908 740 4000
CurrencyMXN - Mexican Peso
You should never invest in Merck without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Merck Stock, because this is throwing your money away. Analyzing the key information contained in Merck's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Merck Key Financial Ratios

Merck's financial ratios allow both analysts and investors to convert raw data from Merck's financial statements into concise, actionable information that can be used to evaluate the performance of Merck over time and compare it to other companies across industries.

Merck Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Merck's current stock value. Our valuation model uses many indicators to compare Merck value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Merck competition to find correlations between indicators driving Merck's intrinsic value. More Info.
Merck Company is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about  0.36  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Merck Company is roughly  2.77 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Merck by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Merck's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Merck Company Systematic Risk

Merck's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Merck volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Execute Function
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Merck Company correlated with the market. If Beta is less than 0 Merck generally moves in the opposite direction as compared to the market. If Merck Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Merck Company is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Merck is generally in the same direction as the market. If Beta > 1 Merck moves generally in the same direction as, but more than the movement of the benchmark.

Merck November 26, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Merck help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Merck Company. We use our internally-developed statistical techniques to arrive at the intrinsic value of Merck Company based on widely used predictive technical indicators. In general, we focus on analyzing Merck Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Merck's daily price indicators and compare them against related drivers.

Additional Tools for Merck Stock Analysis

When running Merck's price analysis, check to measure Merck's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck is operating at the current time. Most of Merck's value examination focuses on studying past and present price action to predict the probability of Merck's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck's price. Additionally, you may evaluate how the addition of Merck to your portfolios can decrease your overall portfolio volatility.